About
AWI Leadership Board
Resources by Tumor Type
Provider Resources
Care Step Pathways
Continuing Education
Provider Toolkits
JADPRO AIM with Immunotherapy Supplement
JCO OP AIM with Immunotherapy Supplement
Facebook Provider Community
News
Patient Resources
Patient Action Plans
Options for Stage III Melanoma
International Resources
Australia
Canada
France
Germany
Italy
Portugal
Spain
UK
Videos
HCP Videos
Patient Videos
Contact
About
AWI Leadership Board
Resources by Tumor Type
Provider Resources
Care Step Pathways
Continuing Education
Provider Toolkits
JADPRO AIM with Immunotherapy Supplement
JCO OP AIM with Immunotherapy Supplement
Facebook Provider Community
News
Patient Resources
Patient Action Plans
Options for Stage III Melanoma
International Resources
Australia
Canada
France
Germany
Italy
Portugal
Spain
UK
Videos
HCP Videos
Patient Videos
Contact
Profile
Topics Started
Replies Created
Engagements
Favorites
@kathleen-m-madden
Profile
Registered: 3 years, 3 months ago
Forums
Topics Started: 0
Replies Created: 0
Forum Role: Moderator
Login
Log In
Username:
Password:
Keep me signed in
Log In
Register
Lost Password
Latest Activity
New BRAF/MEK inhibitors coming to market
topic by
Lisa Kottschade
March 1
in
Dosing and administration
Adjuvant Immunotherapy in stage IIIA patients
topic by
Lisa Kottschade
March 1
in
Expectations for therapy
Influenza and Tamiflu and Immunotherapy
reply by
Kathleen Madden
February 25
in
Other
ASCO/NCCN guidlines now out
reply by
Mollie Reed
February 23
in
Side-effect management
hepatotoxicity
reply by
Mollie Reed
February 23
in
Side-effect management
© 2021 AIM with Immunotherapy. All rights reserved.
